Market Highlights
The Global Non-Alcoholic
Steatohepatitis Biomarkers Market Size is
Expected to Register a CAGR of 20.92% and
is Anticipated to Reach USD 1,960.4 Million by 2024. Non-alcoholic
steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD),
which is characterized by liver inflammation and damage caused by a buildup of
fat in the liver. Currently, there are no noninvasive diagnostic tools approved
for non-alcoholic steatohepatitis.
Growing prevalence of NASH, increasing demand for
non-invasive diagnostic tests, and rising initiatives for creating awareness
are some major factors propelling the growth of the market. Additionally, the
rising prevalence of diabetes and obesity is likely to support market growth.
On the hand, the presence of stringent regulations by the US FDA for the
qualification of biomarkers is anticipated to restrict the market growth during
the assessment period.
Segment Analysis
The global non-alcoholic steatohepatitis biomarkers
market has been segmented by into type and end user. By type, the market has
been segmented into serum biomarkers, hepatic fibrosis biomarkers, apoptosis
biomarkers, oxidative stress biomarkers, and others. By end user, the market
has been segmented into pharmaceutical companies and CROs, research institutes
and academics, hospitals & clinics, diagnostic centers, and others.
Market Players
Market Research Future (MRFR) recognizes the
following companies as the key players in the
global non-alcoholic steatohepatitis biomarkers market that includes are BioPredictive (France), Celerion (US), Cisbio (France), Echosens
(France), Enterome (France), GENFIT (France), Laboratory Corporation of America
Holdings (US), NGM Biopharmaceuticals (US), One Way Liver, SL (Spain), Pacific
Biomarkers (US), Prometheus Laboratories Inc (US), Perspectrum Diagnostics Ltd
(UK), Quest Diagnostics, Regulus Therapeutics, Inc. (US), Siemens Healthineers
(Germany), Shenzhen New Industries Biomedical Engineering Co., Ltd (China), and
Xeptagen SpA (Italy)
Access Report Details @ https://www.marketresearchfuture.com/reports/non-alcoholic-steatohepatitis-biomarkers-market-7984
Regional Analysis
Geographically, the Americas is expected to dominate
the global non-alcoholic steatohepatitis biomarkers market. The growth in this
region can be attributed to the favorable government initiatives, the presence
of sophisticated healthcare infrastructure, and rising prevalence of diabetes,
fatty liver disease, and obesity. Europe is anticipated to hold the second
position in the global market owing to the factors such as growing incidence of
NASH, increasing prevalence of obesity and diabetics, and increasing research
and development on liver diseases. In the Asia-Pacific region, the market
growth is mainly due to the factors such as the presence of a large patient
base, increase in healthcare spending, and availability of skilled healthcare
personnel. The Middle East and Africa is anticipated to register the lowest
share in the global market. In the African region, the market is likely to be negatively
affected by factors such as poor healthcare infrastructure, less disposable
income, limited awareness about liver diseases, including NASH.
Key Findings of the Study:
- Global Non-Alcoholic Steatohepatitis Biomarkers Market is projected
to reach USD 1,960.4 million by 2024 with 92%
CAGR during the review period of 2019
to 2024.
- Americas accounted for the largest share in the region due to the
growing demand of non-invasive diagnostics for NASH.
- The pharmaceutical companies and CROs segment accounted for the
largest share, holding a market value of USD 226.7 million in 2018.
About Market Research Future:
At Market Research Future (MRFR),
we enable our customers to unravel the complexity of various industries through
our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
MRFR team have supreme objective
to provide the optimum quality market research and intelligence services to our
clients. Our market research studies by Components, Application, Logistics and
market players for global, regional, and country level market segments, enable
our clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with
technology and work process of the industry, MRFR often plans & conducts
meet with the industry experts and industrial visits for its research analyst
members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on
various industry verticals and wherever required we will be considering covid19
footprints for a better analysis of markets and industries. Cordially get in
touch for more details.
